Comparison between an artificial neural network and logistic regression in predicting acute graft-vs-host disease after unrelated donor hematopoietic stem cell transplantation in thalassemia patients

Experimental Hematology

Volumn 38, Issue 5, 2010, Pages 426-433

  Caocci, Giovanni ^a   Baccoli, Roberto ^a   Vacca, Adriana ^a   Mastronuzzi, Angela ^b   Bertaina, Alice ^b   Piras, Eugenia ^a   Littera, Roberto ^a   Locatelli, Franco ^c   Carcassi, Carlo ^a   La Nasa, Giorgio ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; HLA G ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; METHOTREXATE; THIOTEPA; THYMOCYTE ANTIBODY; TREOSULFAN;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; AGE; ARTICLE; ARTIFICIAL NEURAL NETWORK; BETA THALASSEMIA; CHILD; COMPUTER PROGRAM; CONTROLLED STUDY; DONOR; EXPERIMENTAL MODEL; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GRAFT SURVIVAL; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMOZYGOSITY; HUMAN; INDIVIDUALIZATION; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ACUTE DISEASE; ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; INFANT; KAPLAN-MEIERS ESTIMATE; LIVING DONORS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PROGNOSIS; RANDOM ALLOCATION; RECEPTORS, KIR; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951469347     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.02.012     Document Type: Article

References (41)

1. Hansen J.A., Gooley T.A., Martin P.J., et al. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukaemia. N Engl J Med 1998, 228:962-968.
2. Caocci G., Pisu S., Argiolu F., et al. Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues. Bone Marrow Transplant 2006, 37:165-169.
3. Borgna Pignatti C., Rugolotto S., De Stefano P., et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004, 89:1187-1193.
4. Thomas E.D., Buckner C.D., Sanders J.E., et al. Marrow transplantation for thalassemia. Lancet 1982, 2:227-229.
5. Lucarelli G., Galimberti M., Polchi P., et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990, 322:417-421.
6. La Nasa G., Caocci G., Argiolu F., et al. Unrelated donor stem cell transplantation in adult patients with thalassemia. Bone Marrow Transplant 2006, 36:971-975.
7. Lucarelli G., Giardini C., Angelucci E. Bone marrow transplantation in thalassemia. Blood Stem Cell Transplantation 1997, 305-315. Kluwer Academic, Boston, MA. J.N. Winter (Ed.).
8. La Nasa G., Littera R., Locatelli F., et al. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients. Biol Blood Marrow Transplant 2007, 13:1358-1368.
9. La Nasa G., Littera R., Locatelli F., et al. The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia. Br J Haematol 2007, 139:284-288.
10. Littera R, Orrù N, Vacca A, et al. The role of killer immunoglobulin-like receptor (KIR) haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia. Bone Marrow Transplant. 2010 Feb 22. [Epub ahead of print.].
11. Fleischhauer K., Locatelli F., Zecca M., et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood 2006, 107:2984-2992.
12. Royston P. A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat Med 2000, 19:1831-1847.
13. Harrell F.E., Lee K.L., Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387.
14. Schwarzer G., Vach W., Schumacher M. On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Stat Med 2000, 19:541-561.
15. Linder R., König I.R., Weimar C., Diener H.C., Pöppl S.J., Ziegler A. Two models for outcome prediction-a comparison of logistic regression and neural networks. Methods Inf Med 2006, 45:536-540.
16. Dreiseitl S., Ohno-Machado L. Logistic regression and artificial neural network classification models: a methodology review. J Biomed Inform 2002, 35:352-359.
17. Schumacher M., Olschewski M., Schwarzer G. Contributions of artificial neural networks to knowledge in clinical medicine-is there evidence for improvement?. Biomed J 2004, 46:39.
18. Bassi P., Sacco E., De Marco V., Aragona M., Volpe A. Prognostic accuracy of an artificial neural network in patients undergoing radical cystectomy for bladder cancer: a comparison with logistic regression analysis. BJU Int 2007, 99:1007-1012.
19. Zini G. Artificial intelligence in hematology. Hematology 2005, 10:393-400.
20. Zini G., d'Onofrio G. Neural network in hematopoietic malignancies. Clin Chim Acta 2003, 333:195-201.
21. Amendolia S.R., Brunetti A., Carta P., et al. A real-time classification system of thalassemic pathologies based on artificial neural networks. Med Decis Making 2002, 22:18-26.
22. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974, 18:295-304.
23. Thomas E.D., Storb R., Clift R.A., et al. Bone marrow transplantation (second of two parts). N Engl J Med 1975, 292:895-902.
24. Zino E., Frumento G., Marktel S., et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004, 103:1417-1424.
25. Uhrberg M., Parham P., Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 2002, 54:221-229.
26. Natarajan K., Dimasi N., Wang J., Mariuzza R.A., Margulies D.H. Structure and function of natural killer cell receptors: multiplemolecular solution to self, nonself discrimination. Annu Rev Immunol 2002, 20:853-885.
27. Colonna M., Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995, 268:405-408.
28. Hansasuta P., Dong T., Thananchai H., et al. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 2004, 34:1673-1679.
29. Cook M.A., Milligan D.W., Fegan C.D., et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004, 103:1521-1526.
30. Harrison G.A., Humphrey K.E., Jakobsen I.B., Cooper D.W. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993, 2:2200.
31. Kalogirou Soteris A. Artificial neural networks in renewable energy systems applications: a review. Renew Sustain Energy Rev 2001, 5:373-401.
32. Demuth H., Beale M., Hagan M. Neural Network Toolbox™ 6. User's Guide 2008, The MathWorks, Inc, Natick, MA.
33. Borgna-Pignatti C. Surviving with thalassemia major: the Italian experience. Pediatr Hematol Oncol 2007, 24:75-78.
34. Giardini C., Lucarelli G. Bone marrow transplantation for betathalassemia. Hematol Oncol. Clin North Am 1999, 13:1059-1064.
35. Lucarelli G., Galimberti M., Polchi P., et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 1993, 329:840-844.
36. Lucarelli G., Galimberti M., Giardini C., et al. Bone marrow transplantation in thalassemia. The experience of Pesaro. Ann NY Acad Sci 1998, 850:270-275.
37. Lucarelli G., Clift R., Galimberti M., et al. Bone marrow transplantation in adult thalassemic patients. Blood 1999, 93:1164-1167.
38. La Nasa G., Argiolu F., Giardini C., et al. Unrelated bone marrow transplantation for beta-thalassemia patients: the experience of the Italian Bone Marrow Transplant Group. Ann N Y Acad Sci 2005, 1054:186-195.
39. Bernardo M.E., Zecca M., Piras E., et al. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major. Br J Haematol 2008, 143:548-551.
40. Hsu K.C., Keever-Taylor C.A., Wilton A., et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 2005, 105:4878-4884.
41. Paczesny S., Hanauer D., Sun Y., Reddy P. New perspectives on the biology of acute GVHD. Bone Marrow Transplant 2010, 45:1-11.